PhaseBio Pharmaceuticals Inc
DelistedCIK 1169245fmd_0JBJM9WPVJD9FVMG6JKJGKG7ZVManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2017 to Jun 30, 2022, 20 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| Total revenues | – | 1 | 2 | 0 | 11 |
| Research and development | 6 | 15 | 31 | 72 | 102 |
| Total operating expenses | 9 | 20 | 42 | 85 | 118 |
| Operating income | (9) | (20) | (40) | (85) | (107) |
| Interest expense | 3 | 4 | 1 | 1 | 1 |
| Interest and investment income | 0 | 0 | 2 | 0 | 0 |
| Other non-operating income (expense) | (2) | (4) | 0 | (14) | (22) |
| Income before taxes | – | – | – | (99) | (129) |
| Income tax expense | 0 | 0 | 0 | 0 | 2 |
| Net income from continuing operations | – | – | – | (99) | (131) |
| Net income | (10) | (24) | (39) | (99) | (131) |